Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Pro-Pharmaceuticals and Mount Sinai School of Medicine to evaluate galectin-targeting agents

Dec. 28, 2010

Meda obtains rights to market EpiPen auto-injector in Europe

Dec. 27, 2010

Novo Nordisk and Emisphere to develop oral insulin for diabetes

Dec. 23, 2010

GSK and Impax collaborate on late-stage Parkinson's disease therapeutic

Dec. 21, 2010

Bristol-Myers Squibb and Oncolys sign licensing agreement for festinavir

Dec. 21, 2010

Lpath enters into an option license agreement with Pfizer for iSONEP

Dec. 21, 2010

Recordati and Nymox sign licensing agreement for NX-1207 in BPH

Dec. 20, 2010

Adimab to collaborate with Lilly, Genentech and Human Genome Sciences

Dec. 17, 2010

Lundbeck, Zenobia and Vernalis to codevelop dardarin inhibitors

Dec. 17, 2010

Serodus licenses RO-1160367 from Roche

Dec. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...